Clinical Trial Update: Effects of Coenzyme Q10 in PSP and CBD [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update notes completion of Phase 2/Phase 3 studies evaluating coenzyme Q10 for Progressive Supranuclear Palsy and corticobasal degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corticobasal Degeneration
• Progressive Supranuclear Palsy

Drugs mentioned

• Coenzyme Q10 (Coenzyme Q10)

Snippet

Sponsor: Lahey Clinic | Conditions: Progressive Supranuclear Palsy, Neurological Disorders | Phase 2, Phase 3 | Status: COMPLETED